Clinicopathology Profile and Bone Involvement of Multiple Myeloma Patients in Dharmais National Cancer Hospital, Indonesia

Asian Pac J Cancer Prev. 2015;16(15):6261-5. doi: 10.7314/apjcp.2015.16.15.6261.

Abstract

Background: Even though rarely found in Indonesia, the incidence of multiple myeloma (MM) is increasing every year. Bone involvement of MM is the most often a clinical disorder which leads to worsening clinical conditions and low quality of life of patients.

Purpose: To determine the clinicopathology profile of bone involvement of MM patients in Indonesia.

Materials and methods: The cross-sectional study of MM conducted at Dharmais National Cancer Hospital (DNCH) by collecting data from medical records of MM patients who came to DNCH in period 2008-2012.

Results: There were 39 MM patients all with age above 60 years. There were 56.4% male and 43.6% female patients. Most were diagnosed at stage III (32.4%), and 41% had obesity. The comorbid conditions were anemia (82.9%), hypoalbuminemia (60%), increased creatinine level (38.5%), increased β2 microglobulin level (94.1%), increased LDH level (23.1%) and plasmocytes above 30% (65%), but only 4.2% patients presented with hypercalcemia. Meanwhile, bone involvement occurred in 76.9% of MM patients with 4 lesions on average and a maximum of 16 lesions. The locations of bone lesions were spine (70%), skull (70%), pelvis (33.3%), humerus (30%), and femur (30%).

Conclusions: The incidence of MM in Indonesia is increasing annually with bone involvement in more than three-fourths, but interestingly without hypercalcemia.

MeSH terms

  • Adult
  • Anemia / etiology
  • Cell Count
  • Creatinine / blood
  • Cross-Sectional Studies
  • Female
  • Femoral Neoplasms / secondary*
  • Humans
  • Humerus
  • Hypercalcemia / etiology
  • Hypoalbuminemia / etiology
  • Indonesia
  • L-Lactate Dehydrogenase / blood
  • Male
  • Middle Aged
  • Multiple Myeloma / blood
  • Multiple Myeloma / complications*
  • Multiple Myeloma / pathology*
  • Pelvic Bones
  • Plasma Cells
  • Skull Neoplasms / secondary*
  • Spinal Neoplasms / secondary*
  • beta 2-Microglobulin / blood

Substances

  • beta 2-Microglobulin
  • Creatinine
  • L-Lactate Dehydrogenase